uniQure to Participate in Multiple Upcoming Industry Conferences in March
March 02, 2023 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 02, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
uniQure Announces 2022 Financial Results and Highlights Recent Company Progress
February 27, 2023 07:05 ET
|
uniQure Inc.
~ Achieved U.S. and European Commission marketing approvals of first and only gene therapyfor adults with hemophilia B ~ ~ Advancing development of AMT-130 for patients with Huntington’s disease –...
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 20, 2022 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Dec. 20, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
uniQure announces FDA approval of first gene therapy for adults with hemophilia B
November 22, 2022 16:40 ET
|
uniQure Inc.
~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX...
uniQure Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
November 02, 2022 07:05 ET
|
uniQure Inc.
~ Patient enrollment at the higher dose of AMT-130 to resume in European Phase Ib/II study following Data Safety Monitoring Board recommendation ~~ U.S. and European pre-approval inspections of...
uniQure Announces Multiple Presentations at the Upcoming Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)
October 11, 2022 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 11, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
ÜberStrategist, a Leading Interactive Entertainment and Tech PR and Marketing Agency, Debuts on the Prestigious 2022 Inc. 5000 Annual List
August 16, 2022 07:00 ET
|
UberStrategist
MORRISVILLE, N.C. , Aug. 16, 2022 (GLOBE NEWSWIRE) -- ÜberStrategist, a leading North American public relations and full-service marketing agency focused on global video game, entertainment, and...
AviadoBio Appoints Dr. David Cooper as Chief Medical Officer
August 02, 2022 07:00 ET
|
Aviadobio Ltd
AviadoBio Appoints Dr. David Cooper as Chief Medical Officer A neurosurgeon with more than 20 years’ biopharmaceutical experience and proven expertise in gene therapy and rare diseasesHas supported...
AITX's Subsidiary Robotic Assistance Devices Announces ‘Bailey’s Gift’ Campaign Donating Firearm Detection Devices to Schools
July 19, 2022 08:40 ET
|
Artificial Intelligence Technology Solutions, Inc.
Detroit, Michigan, July 19, 2022 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), along with its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD)...
uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
June 23, 2022 07:05 ET
|
uniQure Inc.
~ Treatment generally well-tolerated with no significant safety issues related to AMT-130 in treated patients through one year of follow-up ~ ~ A mean reduction of 53.8% of mutant HTT (mHTT) observed...